MPC1 regulates endotoxin tolerance of macrophages through mitochondrial oxidative stress resistance

Yan Liu1, Feng Qi2, Hongrui Zeng1

  • 1Department of Hepatobiliary Surgery, Chongqing University Three Gorges Hospital, Chongqing, China.

Cellular Immunology
|April 30, 2026
PubMed

Insights

Mitochondrial pyruvate carrier 1 (MPC1) plays a key role in regulating endotoxin tolerance in macrophages. MPC1 influences mitochondrial oxidative stress resistance, impacting inflammatory responses and sepsis treatment potential.

Area of Science:

  • Immunology
  • Cell Biology
  • Mitochondrial Biology

Background:

  • Endotoxin tolerance is crucial for sepsis regulation, but its mechanisms are unclear.
  • Macrophages play a central role in the immune response to sepsis.

Purpose of the Study:

  • To investigate the role of mitochondrial pyruvate carrier 1 (MPC1) in regulating endotoxin tolerance in macrophages.
  • To elucidate the mechanisms by which MPC1 influences inflammatory responses and oxidative stress.

Main Methods:

  • Studied MPC1 expression in macrophages from in vitro and in vivo sepsis models.
  • Manipulated MPC1 levels (overexpression) to assess its impact on inflammatory responses and oxidative stress.
  • Investigated the role of mitochondrial reactive oxygen species (mtROS) and the SIRT3/SOD2 pathway.

Main Results:

  • MPC1 expression decreased in sepsis models but increased in LPS-tolerant macrophages.
  • MPC1 overexpression reduced LPS-induced inflammation and oxidative stress, but impaired endotoxin tolerance.
  • MPC1 inhibited mtROS-mediated mitochondrial oxidative stress resistance, weakening macrophage tolerance to secondary LPS stimulation.
  • mtROS, regulated by SIRT3/SOD2, is essential for MPC1's control over mitochondrial oxidative stress resistance and endotoxin tolerance.

Conclusions:

  • MPC1 is a novel regulator of inflammation and endotoxin tolerance in macrophages.
  • MPC1 modulates mitochondrial oxidative stress resistance through mtROS, impacting sepsis progression.
  • Targeting MPC1 presents a potential therapeutic strategy for sepsis treatment.